UNSPSC 41202024: Erysipelothrix rhusiopathiaeserological reagents

In this classification, Erysipelothrix rhusiopathiae serological reagents are devices used in test to identify specific Erysipelothrix rhusiopathiae antibodies in serum. US FDA regulates Erysipelothrix rhusiopathiae serological reagents under 21 CFR 866.3250 and under FDA product code GSD.

UNSPSC 41202024 Erysipelothrix rhusiopathiae serological reagents is a Commodity code with minimal recent state and local procurement activity aligned to its nominal scope. The code designation names a specific bacterial serological reagent used in veterinary or food-safety diagnostics, but the recent opportunities tagged under this code reflect a fundamental mismatch: state and local buyers are soliciting HIV, syphilis, and hepatitis testing reagents and related laboratory services—not Erysipelothrix testing products. The Illinois Department of Public Health has posted multiple procurements for HIV and syphilis reagents manufactured by Abbott Laboratories (including an emergency sole-source contract executed February through May 2026 for $38,079.50), and the City of Austin and Texas Department of Criminal Justice have each solicited HIV rapid test kits and forensic laboratory services. The University of Houston sought clinical diagnostic laboratory services including blood chemistry reagents. None of these opportunities call for erysipelothrix serological reagents; the code tagging appears to reflect a cataloging error rather than genuine procurement demand under this commodity heading.

State and local buyers in Texas, Illinois, and elsewhere are actively acquiring HIV and syphilis testing kits, screening assays, instrumentation, and laboratory testing services, but this activity does not align with UNSPSC 41202024. The Collin County Community Supervision and Corrections Department issued an RFP (2026-327, due July 23, 2026) for offender specimen collection and drug testing services valued at approximately $600,000 annually; the Illinois Department of Public Health issued an IFB (26482DPHOFCDIB50489, due March 16, 2026) for a five-year contract for hepatitis, HIV, and syphilis screening assays and instrumentation with estimated annual test volumes exceeding 30,000 tests; and the Texas Department of Criminal Justice solicited forensic analysis services including serology and DNA testing (RFP 696-IG-26-P034, due May 13, 2026). Unless your firm manufactures or supplies erysipelothrix diagnostic products to state or local public health laboratories, this code shows no actionable procurement opportunity at present.